Qdata® Prostate Cancer Powers Quality Insights Only Found Here

Leverage Qdata® Prostate Cancer with data on more than 500,00+ patients with an average of 4.3 years of follow-up data to support clinical trial design, better understand the patient journey for treated patients and more.

Get exclusive access to primary measures such as PSA level, Gleason score, TNM staging, and more.


Read the Announcement 

Learn More About Qdata®   

Meet with Verana Health

About Qdata®

Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes.

Qdata spans ophthalmology, neurology, and urology to help life sciences teams unlock quality insights across the entire drug and device development cycle.

Learn more about Qdata

Why Qdata Prostate Cancer for your Next RWE Project?


Exclusive Insights into the Prostate Cancer Population

Only found here from the AQUA Registry


Unique Understanding of Prostate Cancer Disease Progression

View prostate cancer biomarkers such as PSA level or Gleason score


Earlier View into the Prostate Cancer Patient Journey

View into treatment path choices from Urologist electronic health records (EHRs)

Qdata® Prostate Cancer By the Numbers


Curated data available in this Qdata module, based on your research needs

Screenshot 2022-06-30 2.18.17 PM


Total patients with Prostate Cancer*

Time Icon

4.3 Years

Average length of follow-up for total patients

Screenshot 2022-06-30 2.18.24 PM


Total Patients with Prostate Cancer with linked claims**

Time Icon

2.2 Years

Average length of follow-up for patients with linked claims**


*Defined as patients in AQUA Registry who (1) either of the "Malignant neoplasm of prostate" ICD codes (ICD-9-CM 185 or ICD-10-CM C61); AND (2) a Gleason score of 6 or above.

**Year > 2015 linked with open or closed Komodo Health medical/pharmacy claims data with minimum 1 claim.
Data Current to October 2022

Meet with a Qdata Expert Today


Key Variables in Qdata® Prostate Cancer Module


Unstructured Data Enables Deeper Understanding

Verana Health applies physician-informed algorithms to unstructured EHR data at scale to help extract key information on PSA levels, Gleason scores, and other measures, which can then be analyzed across large populations in a reliable manner.

This can give providers, researchers, and life science companies unprecedented insights into the journey of patients with prostate cancer.

One example is the staging information:

80% of medical data remains unstructured

Screenshot 2022-06-30 2.18.44 PM

TNM Stage Documented (clinical or pathological)

T Stage

300K Patients

N Stage

175K Patients


M Stage

130K Patients


Talk to a Qdata® Expert

Take a minute to submit your contact information and one of our team members will reach out to you.

About Verana Health

Verana Health® is a digital health company elevating quality in real-world data. Verana Health manages the clinical data registries for leading medical societies, including the American Academy of Neurology. Using its clinician-informed VeraQ®  population health data engine, Verana Health supports providers with quality reporting requirements for the merit-based incentive payment system (MIPS) as well as offers opportunities for clinical trial participation and academic research. Verana Health’s quality data and insights help drive progress in medicine to enhance the quality of care and quality of life for patients.

For more information, visit www.veranahealth.com.